Literature DB >> 6518034

An experimental circulatory arrest model in the rat to evaluate calcium antagonists in cerebral resuscitation.

L de Garavilla, C F Babbs, W A Tacker.   

Abstract

A circulatory arrest model in the rat was developed for use in cerebral and cardiac resuscitation studies. Whole-body ischemia was produced for 8 to 18 minutes by arresting the heart with a cold potassium chloride cardioplegic solution. Following cardiopulmonary resuscitation, minimal, standardized intensive care was provided. As the duration of ischemia was increased from 8 to 18 minutes, survival immediately following resuscitation decreased from 100% to 25%, and survival at 48 hours after ischemia decreased from 60% to 0%. Thirty per cent of the rats recovering from 11 minutes of ischemia suffered motor seizures. Survival and the incidence of motor seizures appear to be good measures of outcome following ischemic circulatory arrest. These measures can be used to test the possible anti-ischemic actions of calcium antagonists or other drugs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6518034     DOI: 10.1016/0735-6757(84)90127-X

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat.

Authors:  P A Calle; M G Bogaert; L De Ridder; W A Buylaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

Review 2.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

3.  Thoracotomy in the emergency department for resuscitation of the mortally injured.

Authors:  J Christopher DiGiacomo; L D George Angus
Journal:  Chin J Traumatol       Date:  2017-05-10

4.  Adenosine A3 receptor stimulation and cerebral ischemia.

Authors:  D K Von Lubitz; R C Lin; P Popik; M F Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-09-22       Impact factor: 4.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.